SCHEMBL8303556

SCHEMBL8303556

c1ccc(CC2COC(N3CCN(CCCCc4ccsc4)CC3)CO2)cc1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.43
CCR3 P51677 2/20 0.43
MEN1 O00255 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
DRD2 P14416 1/20 0.38
HTR2B P41595 1/20 0.38
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8303201 0.97 SIGMAR1 (0.43) SIGMAR1CCR3DRD2HTR2BOPRM1
SCHEMBL8303871 0.93 OPRM1 (0.42) SIGMAR1CCR3DRD2OPRM1OPRD1
SCHEMBL8306497 0.86 SIGMAR1 (0.42) SIGMAR1CCR3KMT2AOPRM1OPRD1
SCHEMBL8303444 0.86 SIGMAR1 (0.55) SIGMAR1CCR3MEN1TP53CYP1A2
SCHEMBL8304636 0.79 OPRM1 (0.41) CCR3DRD2OPRM1OPRD1OPRK1
SCHEMBL8121244 0.76 HTR7 (0.58) MEN1CYP1A2CYP3A4CYP2D6KMT2A
SCHEMBL9175467 0.76 SIGMAR1 (0.40) SIGMAR1CCR3
SCHEMBL9179831 0.76 SIGMAR1 (0.38) SIGMAR1CCR3MEN1TP53CYP1A2
SCHEMBL9143193 0.75 DRD2 (0.39) CCR3DRD2
SCHEMBL9176466 0.74 SLC6A2 (0.37) SIGMAR1CCR3MEN1TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0574313-B1 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders ADIR (FR) 1999-10-06 EP disclosed
US-5464834-A Antidepressants, central nervous system ADIR ET COMPAGNIE (FR) 1995-11-07 US disclosed
EP-0574313-A1 1,4-Disubstituted piperazines for the treatment of disorders of the central nervous system and neuro-endocrine disorders ADIR ET COMPAGNIE (FR) 1993-12-15 EP disclosed